U.S. Industrial REITs Stock News

Ionis Pharmaceuticals announced that the U.S. FDA has approved DAWNZERA™ (donidalorsen) to prevent hereditary angioedema (HAE) attacks in patients aged 12 and older, following strong Phase 3 efficacy results and a favorable safety profile. DAWNZERA is now the first and only RNA-targeted therapy approved for HAE, offering patients a new self-administered option that showed significant reductions in attack rates and high preference among those switching from existing treatments. We'll look at...

If you have been eyeing Home Depot stock lately, you are not alone. Plenty of investors are weighing what to do after seeing the company's shares climb over 11% this past year and more than 55% in five years. The biggest home improvement retailer in the US has shown real resilience, especially with a steady flow of headlines and rumors about deals, including a recent buzz over its bid for GMS Inc. Even after a short-lived dip earlier in the year, Home Depot’s quick recovery signals that Wall...

Block (NYSE:XYZ) has recently caught investors’ attention with a dip in its share price, closing at $74.09 after shedding nearly 7% over the past month. There is no single dramatic headline driving this move, but the price action is hard to ignore, especially for investors trying to judge whether the drop is an early signal of changing sentiment or simply noise. For anyone considering adding to or trimming their position, the real question becomes whether this pullback offers genuine value or...

Triumph Financial, Inc. was recently dropped from the NASDAQ Composite Index and, as of August 19, 2025, shifted its primary exchange listing to the New York Stock Exchange. This dual development often prompts portfolio rebalancing by index funds and may influence liquidity and trading patterns for impacted companies. We’ll now explore how Triumph Financial’s migration to the NYSE could shape its investment narrative and future prospects. We've found 21 US stocks that are forecast to pay a...

Earlier this month, Parsons Corporation announced the successful launch of New Jersey's first integrated Statewide Advanced Traffic Management System for NJDOT, powered by the iNET smart mobility platform, and the company was also awarded a US$30 million recompete contract to support defense radar development for the U.S. Army C5ISR Center. These achievements highlight Parsons' growing influence in both smart infrastructure and national defense technology, underscored by industry recognition...

If you are watching CAVA Group's stock and feeling torn over your next move, you are definitely not alone. The past year has been a wild ride, with CAVA's share price swinging notably over both the short and long term. In just the last month, the stock has slipped about 25%, and year-to-date it is down over 41%. That kind of volatility always catches the eye, especially for a company like CAVA, which has posted steady annual revenue growth of around 17% and net income growth close to...

Earlier this week, Academy Sports + Outdoors and Whataburger announced a new limited-time collaboration, offering co-branded merchandise such as an exclusive Hey Dude shoe, apparel, coolers, and outdoor games that blend the unique styles of both well-known Texas brands. This marks the third collaboration between the companies, highlighting the potential for themed, regionally inspired product lines to engage loyal customer bases and boost in-store and online activity. We'll explore how this...

Earlier this week, Charles River Associates (CRA) announced the appointment of Chris Rucinski as Vice President to expand its Forensic Services Practice, adding significant expertise in intellectual property and technology disputes. This addition reflects CRA's intent to enhance its ability to address complex software and hardware analyses for clients facing high-stakes litigation and technical challenges. We'll explore how enhanced forensic expertise supports CRA's investment story by...

GitLab (GTLB) shares have nudged upward by just over 1% in the past day, a move that might catch the eye of investors wondering what’s next for this developer-focused software platform. While there is no headline-grabbing announcement driving the action, even modest shifts in stock price can be a signal for shareholders to revisit what is baked into the valuation. Sometimes, these small changes reflect shifting investor sentiment rather than any fundamental change in the company’s...

Earlier this week, Oppenheimer analyst Brian Schwartz reaffirmed an Outperform rating on Freshworks following post-earnings meetings with the CFO, highlighting the company's strong market position and advancements in artificial intelligence. The emphasis on Freshworks’ large, underpenetrated market and AI-driven business momentum underscores its potential for product-led growth and expansion into adjacent workflow markets. We'll assess how the renewed analyst confidence in Freshworks' AI...

McKesson (MCK) turned some heads this week after a small climb in its share price drew fresh attention from investors weighing their next move. While there was no headline-grabbing event to explain the latest uptick, subtle shifts often leave market-watchers curious: are these signals of changing sentiment or simply noise in the short run? With McKesson’s footprint spanning pharmaceutical distribution and healthcare services, even incremental moves can hint at evolving dynamics beneath the...

EDEKA Paschmann in Dusseldorf has become the first supermarket in Germany to deploy Diebold Nixdorf’s Vynamic Smart Vision Shrink Reduction and Age Verification AI solutions at self-service checkouts, aiming to minimize errors and speed up the process for shoppers and staff. This rollout highlights early commercial traction for Diebold Nixdorf’s AI-enabled retail technologies, with GDPR-compliant tools designed to address key retailer concerns such as shrinkage and operational...

3M (MMM) is once again drawing interest after its latest quarterly results topped Wall Street expectations, sending the stock up in recent trading sessions. The company’s net income climbed in part due to a turnaround in its healthcare business and recovery in industrial demand. Both of these factors play a significant role in 3M’s long-term narrative. For shareholders who have been waiting for clearer signs of progress, this earnings beat represents a shift from the uncertainty that has...

Unfortunately for some shareholders, the Kaltura, Inc. ( NASDAQ:KLTR ) share price has dived 27% in the last thirty...

Investors in Sarepta Therapeutics (SRPT) have likely noticed the stock’s pronounced swings recently, with a sharp drop in the past year now giving way to a month of strong gains. There has not been any major breaking event or market-moving update to explain this renewed enthusiasm, which makes the sudden change in sentiment all the more intriguing. For those holding SRPT or considering an entry, this move might feel like a signal, though it is not clear yet whether it represents sustainable...

If you have been watching Albemarle’s stock lately, you have probably wondered whether now is the right moment to make a move. The company has been on quite a ride this year, swinging from sharp dips to surprising rebounds. In just the past three months, shares have soared more than 37%, clawing back from significant lows after a challenging year. At the same time, Albemarle’s one-year total return is still down about 7%, reflecting both the pressures from volatile lithium prices and shifting...

Earlier this week, Harmonic announced new AI-powered capabilities for its VOS360 Ad SaaS platform, enabling precise, contextual ad insertion for live streams and the introduction of advanced programmatic workflows for broadcasters. This innovation opens fresh revenue streams for broadcasters and content providers, especially in live sports, by integrating automated ad delivery through seamless connections with top advertising platforms. We'll now examine how Harmonic's AI-driven ad...

Life Time Group Holdings (LTH) just rolled out LTH Dream, a magnesium-based, melatonin-free sleep support powder. This new product fits right in with Life Time’s push to offer wellness solutions that address real consumer concerns, in this case, better sleep without side effects. It lands alongside another sign of growth, as Life Time opens a sleek new athletic country club in Atlanta that caters to health-focused professionals and families looking for community, fitness, and recovery, all...

If you have been watching Udemy (UDMY) lately, there is a good chance that its recent moves have caught your attention. The company just unveiled an Arabic-language version of its platform, a step that could open up access to more than 300 million potential learners across the Middle East and North Africa. In addition, Udemy named Ramji Sundararajan, an executive with a proven track record in digital consumer businesses, as its new President of Consumer. Together, these actions seem aimed at...

If you have been watching Baidu’s stock lately, you are not alone. Investors everywhere are debating whether it is time to pounce, hold tight, or look elsewhere. Baidu’s share price has been on a bit of a journey, rising 0.9% over the past day but showing slight declines over the past week and month. The picture starts to shift if you zoom out. Despite modest year-to-date gains of around 6%, much longer-term returns have been tougher, with three- and five-year results still in the red. But...

So, you are keeping an eye on Cummins stock and wondering whether it should find a place in your portfolio, or if it is time to lock in gains. You are not alone. Cummins has caught plenty of attention lately, both for its steady performance and for the market noise swirling around industrial names. In just the past year, the stock has soared roughly 32% higher, a move that has left some investors impressed and others hesitant, asking whether the run can continue. The most recent momentum is...

If you are considering what to do with HCA Healthcare stock right now, you are not alone. The stock has sparked plenty of interest lately, and for good reason, as its recent price movements have left investors debating whether to buy, sell, or simply hold tight. Over just the past month, HCA shares have soared by more than 15%, and year-to-date the stock is up a striking 35.8%. This momentum stands out in the healthcare sector. Longer-term gains are also notable, with HCA delivering a total...

This past week, Weyerhaeuser (WY) caught the market’s eye after the stock slipped nearly 1% in a single day, extending what has been a choppy stretch for shareholders. The move follows no major company announcement. When shares of a high-profile timber and land REIT drift lower, it raises the question: is this noise or a sign of something deeper? For investors weighing whether to hold, add, or stand aside, the short-term dip is worth a closer look, especially when paired with Weyerhaeuser’s...

Jazz Pharmaceuticals (JAZZ) just turned heads with a major licensing agreement: the company secured exclusive worldwide rights to develop and commercialize Saniona’s SAN2355, a preclinical therapy designed to address key shortcomings in existing epilepsy treatments. This move, coming on the heels of bringing in new CEO Renee Gala, could signal renewed ambition as Jazz looks to build out its neurological pipeline and position itself in the race for next-generation therapeutics. Investors...